You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Active secondary progressive Multiple Sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

Recruiting
  • Progressive Multiple Sclerosis
  • Placebo
  • Masitinib (4.5)
  • Lille, France
  • +1 more
Jul 1, 2022

Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

Recruiting
  • Active Secondary Progressive Multiple Sclerosis
  • siponimod
  • Ancona, AN, Italy
  • +19 more
Dec 27, 2022

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Multiple Sclerosis Trial (Siponimod)

Available
  • Multiple Sclerosis
  • (no location specified)
Sep 13, 2022

Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

Recruiting
  • Secondary-progressive Multiple Sclerosis
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Oct 10, 2022

Multiple Sclerosis Trial in Latham (Cladribine Tablets)

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022

Measuring Active Microglia in Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
  • [C11]PK-1195 PET scan
  • New York, New York
    Weill Cornell Medical College
Jan 14, 2022

Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Glostrup, Copenhagen, Denmark
  • +11 more
May 3, 2022

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
    • Camperdown, New South Wales, Australia
    • +1 more
    Apr 19, 2023

    Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Nov 15, 2023

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Multiple Sclerosis, Secondary Progressive
    • Tokyo, Japan
      National Center of Neurology and Psychiatry
    Sep 28, 2022

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Metformin Hydrochloride 850 mg Oral Tablet
    • Placebo
    • Brugge, Belgium
    • +4 more
    May 30, 2023

    Multiple Sclerosis (MS) Patients

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
      • (no location specified)
      Dec 15, 2022

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

      Withdrawn
      • Primary Progressive Multiple Sclerosis
      • +2 more
      • Intranasal Foralumab Solution
      • Placebo
      • (no location specified)
      Feb 14, 2022

      Kesimpta for s.c. Injection 20 mg Pen

      Recruiting
      • Relapsing-remitting Multiple Sclerosis
      • Active Secondary Progressive Multiple Sclerosis
      • Kesimpta
      • Ichinomiya, Aichi, Japan
      • +121 more
      Jan 13, 2023

      Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))

      Active, not recruiting
      • Secondary Progressive Multiple Sclerosis
      • BAF312
      • Baseline disease modifying therapies (DMTs)
      • Mittweida, Sachsen, Germany
      • +9 more
      Aug 9, 2022

      Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

      Not yet recruiting
      • Relapsing Remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • Glycemic load
      • +2 more
      • Birmingham, Alabama
      • +1 more
      Jan 4, 2023

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

      Recruiting
      • Multiple Sclerosis
      • +2 more
      • N-acetyl cysteine
      • Placebo
      • San Francisco, California
        University of California, San Francisco
      Mar 22, 2022

      Mitochondrial Dysfunction in Primary Progressive Multiple

      Recruiting
      • Multiple Sclerosis
        • Milan, MI, Italy
        • +1 more
        Aug 29, 2023

        Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)

        Not yet recruiting
        • Multiple Sclerosis
        • Progressive Multiple Sclerosis
        • Nicotinamid riboside
        • Placebo
        • Bergen, Norway
          Haukeland University Hospital
        Feb 22, 2023

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

        Active, not recruiting
        • Secondary Progressive Multiple Sclerosis
        • +2 more
        • Minneapolis, Minnesota
        • +2 more
        Mar 29, 2022

        Multiple Sclerosis, Chronic Progressive, High-Intensity Interval Training, Motor Symptoms Trial in Valens (HIIT, MCT)

        Recruiting
        • Multiple Sclerosis, Chronic Progressive
        • +2 more
        • HIIT
        • MCT
        • Valens, Sankt Gallen, Switzerland
          Klinik Valens, Valens rehabilitation clinic
        Oct 12, 2022

        Microglia in the Pathogenesis of Progressive Multiple Sclerosis

        Active, not recruiting
        • Multiple Sclerosis
          • Turku, Finland Proper, Finland
            Turku PET Centre
          Oct 12, 2022

          Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

          Not yet recruiting
          • Primary Progressive Multiple Sclerosis
          • Ocrelizumab
          • Buffalo, New York
            Buffalo Neuroimaging Analysis Center
          Jul 26, 2023